• Business & Finance

    PharmaTher Provides Business Update and Releases Financial Results for the First Quarter of Fiscal 2022

    TORONTO, Oct. 27, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today released its business update and financial results for the three months ended August 31, 2021. All amounts are stated in Canadian dollars unless otherwise indicated. “To date, we have made tremendous progress across all drug programs including the initiation of our FDA Phase 2 clinical study with ketamine to treat Parkinson’s disease, the advancement of KETABET™ to treat depression, the FDA grant of two orphan drug designations for ketamine in the treatment of Amyotrophic Lateral Sclerosis  

    Comments Off on PharmaTher Provides Business Update and Releases Financial Results for the First Quarter of Fiscal 2022
  • Business Abbreviations

    HSBC Bank Canada Third Quarter 2021 Results

    VANCOUVER, British Columbia–(BUSINESS WIRE)–HSBC Bank Canada Linda Seymour, President and Chief Executive Officer of HSBC Bank Canada, said: “This quarter profits are up significantly over this time last year – which itself was a significant improvement over the first two quarters of 2020. Activity and revenues increased across all business lines – with notably higher volumes of bankers’ acceptances, investment funds under management and advisory fees – and profit in Wealth and Personal Banking is at levels not seen since 2012. “Our clients are so appreciative of all that our teams have done to support them, as  

    Comments Off on HSBC Bank Canada Third Quarter 2021 Results
  • Business & Finance

    Ocugen Provides Business Update and Second Quarter 2021 Financial Results

    Conference Call and Webcast Today at 8:30 a.m. ET Rolling regulatory submission to Health Canada completed and review process initiated; U.S. FDA talks continue Multiple milestones achieved across regulatory and supply chain to support potential commercialization of pipeline assets The Company experienced organizational growth to reflect new business requirements in clinical development, manufacturing, and commercialization MALVERN, Pa., Aug. 06, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today reported second quarter 2021  

    Comments Off on Ocugen Provides Business Update and Second Quarter 2021 Financial Results
  • Business & Finance

    RiverNorth Specialty Finance Corporation Announces Final Results of Repurchase Offer

    CHICAGO–(BUSINESS WIRE)–RiverNorth Specialty Finance Corporation (the “Fund”) (NYSE: RSF), a closed-end fund, announced the final results of its repurchase offer for up to 5%, or 227,380 of its outstanding common shares. The repurchase offer expired at 5:00 P.M. Eastern Time on July 7, 2021. Based on information provided by DST Systems, Inc., the depositary for the repurchase offer, a total of 2,645,722 shares were submitted for redemption and 227,380 shares were repurchased. In accordance with the terms and conditions of the repurchase offer, because the number of shares submitted for redemption exceeds the number of shares offered to  

    Comments Off on RiverNorth Specialty Finance Corporation Announces Final Results of Repurchase Offer
  • Business & Finance

    NuCana Reports First Quarter 2021 Financial Results and Provides Business Update

    Bloomberg Deutsche Bank’s Nightmare Decade Is Gone, But Not Yet Forgotten (Bloomberg) — On the day before one of the biggest margin calls in history, Deutsche Bank AG chief Christian Sewing joined an urgent meeting with a not-unfamiliar message: there was a problem, and billions of dollars were at stake.But as executives on the late-March call briefed him on the bank’s exposure to Archegos Capital Management, this time it wasn’t all bad news. Risk managers had been concerned by the family office’s rapid growth for some time, and had been collecting additional collateral. And the firm’s traders stood ready to  

    Comments Off on NuCana Reports First Quarter 2021 Financial Results and Provides Business Update
Exit mobile version